Meryx Inc. logo

Meryx Inc.

Meryx Inc. develops orally bio-available cancer drugs targeting receptor tyrosine kinases. The company focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancers, such as leukemia, lung cancer, and melanoma.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.meryxpharma.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
450 West Drive, CB#7295,NC 27599-7295
Chapel Hill
United States
Email
Contact Number
+1 919 -260-3118

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]